Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions

Potential Target

Regulation of Skeletal Muscle Plasticity by Glycogen Synthase Kinase-3β: A Potential Target for the Treatment of Muscle Wasting

Current Pharmaceutical Design ◽

10.2174/1381612811319180011 ◽

2013 ◽

Vol 19 (18) ◽

pp. 3276-3298 ◽

Cited By ~ 6

Author(s):

Koen J.P. Verhees ◽

Nicholas A.M. Pansters ◽

Annemie M.W.J. Schols ◽

Ramon C.J. Langen

Keyword(s):

Skeletal Muscle ◽

Muscle Wasting ◽

Glycogen Synthase ◽

Muscle Plasticity ◽

Potential Target

Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders

Current Enzyme Inhibition ◽

10.2174/1573408012666161102123222 ◽

2017 ◽

Vol 13 (2) ◽

Cited By ~ 2

Author(s):

Darshit B. Shah ◽

M. Ramanathan

Keyword(s):

Drug Discovery ◽

Neurodegenerative Disorders ◽

Glycogen Synthase ◽

Potential Target

Glycogen synthase kinase-3 alpha

Targeted Protein Database ◽

10.2970/tpdb.2008.169 ◽

2008 ◽

Author(s):

Richard Jope

Keyword(s):

Glycogen Synthase ◽

Glycogen Synthase Kinase 3

Faculty Opinions recommendation of A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1009885.183176 ◽

2003 ◽

Author(s):

Inke Nathke

Keyword(s):

Mitotic Spindle ◽

Glycogen Synthase ◽

Spindle Dynamics ◽

Chromosome Alignment

Faculty Opinions recommendation of Unrestrained glycogen synthase kinase-3 beta activity leads to activated T cell death and can be inhibited by natural adjuvant.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088692.542807 ◽

2007 ◽

Author(s):

E Charles Snow

Keyword(s):

Cell Death ◽

T Cell ◽

Glycogen Synthase ◽

Beta Activity ◽

Activated T Cell

Faculty Opinions recommendation of Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1124909.602412 ◽

2009 ◽

Author(s):

Ron Prywes ◽

Susanne Muehlich

Keyword(s):

Targeted Therapy ◽

Glycogen Synthase ◽

Glycogen Synthase Kinase 3

Faculty Opinions recommendation of Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12581.470066 ◽

2006 ◽

Author(s):

Yukio Hayashi

Keyword(s):

Glycogen Synthase ◽

Glycogen Synthase Kinase 3

Faculty Opinions recommendation of Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9082.466571 ◽

2006 ◽

Author(s):

Dan Kaufman

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell ◽

Glycogen Synthase ◽

Hematopoietic Stem ◽

Cell Repopulation

N-(4-bromophenethyl) Caffeamide Inhibits Melanogenesis by Regulating AKT/Glycogen Synthase Kinase 3 Beta/Microphthalmia-associated Transcription Factor and Tyrosinase-related Protein 1/Tyrosinase

Current Pharmaceutical Biotechnology ◽

10.2174/1389201016666150817094258 ◽

2015 ◽

Vol 16 (12) ◽

pp. 1111-1119 ◽

Cited By ~ 10

Author(s):

Yueh-Hsiung Kuo ◽

Chien-Chia Chen ◽

Ping Lin ◽

Ya-Jhen You ◽

Hsiu-Mei Chiang

Keyword(s):

Transcription Factor ◽

Glycogen Synthase ◽

Related Protein ◽

Tyrosinase Related Protein

Multiple Roles for Glycogen Synthase Kinase-3 as a Drug Target in Alzheimers Disease

Current Drug Targets ◽

10.2174/1389450110607011389 ◽

2006 ◽

Vol 7 (11) ◽

pp. 1389-1397 ◽

Cited By ~ 54

Author(s):

Hui-Chuan Huang ◽

Peter Klein

Keyword(s):

Drug Target ◽

Glycogen Synthase ◽

Multiple Roles ◽

Alzheimers Disease